Call
Patient ReportsCongenital Hyperinsulinism: Diagnosis and Treatments
Written by Medicover Team and Medically Reviewed by Dr Girija Kalyani Pappala , Endocrinologists
Table of Contents
Congenital Hyperinsulinism (CHI) is a rare genetic disorder characterized by the overproduction of insulin by the pancreas, leading to persistent hypoglycemia. This condition can pose significant risks to health, particularly in newborns and infants, making early diagnosis and appropriate management essential.
What are the Symptoms of Congenital Hyperinsulinism?
Recognizing the symptoms of Congenital Hyperinsulinism is crucial for timely diagnosis and treatment. The symptoms can vary but generally include the following:
- Hypoglycemia: Low blood sugar levels that may present as irritability, lethargy, or seizures.
- Poor Feeding and Vomiting: Infants may have difficulty feeding and experience frequent vomiting.
- Hypotonia: Reduced muscle tone that can affect physical development.
- Persistent Hunger: Continuous hunger despite adequate feeding.
- Sweating and Tachycardia: Common autonomic responses to low blood sugar levels.
Because these symptoms can become severe, healthcare providers should promptly evaluate infants who experience persistent hypoglycemia.
What are the Causes of Congenital Hyperinsulinism?
Congenital Hyperinsulinism is primarily caused by inherited genetic mutations that affect the regulation of insulin secretion. Several gene mutations have been identified as responsible for this condition.
Genetic Mutations
- ABCC8 and KCNJ11 Genes: Mutations disrupt the ATP-sensitive potassium channels in pancreatic beta cells, causing excessive insulin production.
- GLUD1 and GCK Genes: These mutations affect glucose metabolism and result in abnormal insulin secretion.
- HADH and SLC16A1 Genes: Less common genetic mutations that can also contribute to Congenital Hyperinsulinism.
Inheritance Patterns
Congenital Hyperinsulinism may be inherited in either an autosomal recessive or autosomal dominant pattern, depending on the affected gene. Identifying the genetic cause helps guide treatment and genetic counseling for affected families.
When to See a Doctor for Congenital Hyperinsulinism?
Congenital Hyperinsulinism is a rare condition in which the pancreas produces excessive insulin, leading to dangerously low blood sugar levels (hypoglycemia). Early diagnosis and treatment are essential to prevent seizures, brain injury, and developmental delays.
If your newborn or child develops symptoms of Congenital Hyperinsulinism, consult an Endocrinologist for prompt evaluation and specialized care.
- Repeated episodes of low blood sugar (hypoglycemia).
- Poor feeding or difficulty feeding.
- Excessive sleepiness, lethargy, or difficulty waking.
- Seizures or unexplained jerking movements.
- Irritability, shakiness, or tremors.
- Bluish skin, lips, or fingernails (cyanosis).
- Difficulty breathing or pauses in breathing.
- Poor weight gain or failure to thrive.
- A family history of Congenital Hyperinsulinism or inherited endocrine disorders.
- Persistent or recurrent low blood sugar despite treatment.
Find Endocrinologists for Congenital Hyperinsulinism Treatment Near You
How is Congenital Hyperinsulinism Diagnosed?
Accurate diagnosis of Congenital Hyperinsulinism involves a combination of clinical evaluation, laboratory investigations, and genetic testing.
Clinical Evaluation
Persistent hypoglycemia along with symp
toms such as seizures, poor feeding, or lethargy raises suspicion for Congenital Hyperinsulinism.
Laboratory Tests
- Blood Glucose Levels: Used to confirm persistent hypoglycemia.
- Insulin Levels: Elevated insulin levels during hypoglycemia strongly suggest hyperinsulinism.
- Critical Sample Analysis: Blood samples collected during hypoglycemia measure insulin, C-peptide, and other metabolic markers to determine the underlying cause.
Genetic Testing
Genetic testing helps identify disease-causing mutations, confirms the diagnosis, and supports treatment planning and genetic counseling.
How is Congenital Hyperinsulinism Treated?
The primary goal of treatment is to maintain normal blood glucose levels and prevent neurological damage caused by recurrent hypoglycemia.
Medical Management
- Diazoxide: First-line medication that reduces insulin secretion, although it may not be effective for all genetic forms.
- Octreotide: A somatostatin analogue used to decrease insulin production when diazoxide is ineffective.
- Glucagon: Administered during severe hypoglycemic episodes to rapidly increase blood glucose levels.
Nutritional Management
Frequent meals and continuous overnight feeding through a nasogastric tube may help maintain stable blood glucose levels, especially in infants.
Surgical Intervention
- Pancreatectomy: Partial or near-total removal of the pancreas may be recommended for severe cases that do not respond to medical therapy.
Long-Term Follow-Up
Children with Congenital Hyperinsulinism require regular follow-up with an Endocrinologist to monitor growth, development, and blood glucose control and to adjust treatment as needed.
Your health is everything - prioritize your well-being today.
Consult Congenital Hyperinsulinism Doctors Today
Frequently Asked Questions
1. What are the causes of Congenital Hyperinsulinism?
Congenital hyperinsulinism is primarily caused by genetic mutations affecting insulin regulation, leading to excessive insulin production and hypoglycemia.
2. What are the symptoms of Congenital Hyperinsulinism?
Symptoms may include persistent hypoglycemia, seizures, irritability, and failure to thrive in infants, requiring careful monitoring and management.
3. How is Congenital Hyperinsulinism diagnosed?
Diagnosis typically involves measuring blood glucose and insulin levels, genetic testing, and clinical evaluation to assess symptoms and metabolic function.
4. What treatment options are available for Congenital Hyperinsulinism?
Treatment focuses on managing blood sugar levels through dietary modifications, medications to inhibit insulin secretion, and, in severe cases, surgical interventions.
5. What are the complications associated with Congenital Hyperinsulinism?
Complications can include neurological damage due to recurrent hypoglycemia, necessitating careful management and monitoring to prevent adverse outcomes.
